46.34 USD
▲+0.09+0.63%
盘后 46.01 -0.09%
2026-08-03
市值
$2.37B
市盈率
98.79
EPS
0.47
股息率
—
52 周区间
28.95 – 49.32
成交量
440.78K
Beta
1.06
目标价
60.57
52W 低 28.9552W 高 49.32
价格走势
公司简介
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use devic...